Bexarotene Reduces Production of CCL22 From Tumor-Associated Macrophages in Cutaneous T-Cell LymphomaKayo Tanita, Setsuya Aiba, Motoki Nakamura et al.|Frontiers in Oncology|2019Cited by 48
Immune checkpoint inhibitor‐induced vitiligo in advanced melanoma could be related to increased levels of CCL19Taku Fujimura, Setsuya Aiba, Hiroshi Uchi et al.|British Journal of Dermatology|2019Cited by 14
578 Immunomodulatory effects of bexarotene on tumor-associated macrophages in patients with mycosis fungoidesKayo Tanita, Setsuya Aiba, Taku Fujimura et al.|Journal of Investigative Dermatology|2017Cited by 1